Announcing a new article publication for Zoonoses journal. Varicella-zoster virus (VZV) is a clinically important human ...

By David Bautz, PhD NASDAQ: COCP READ THE FULL COCP RESEARCH REPORT Business Update Presentation at ICAR 2026 Showcases ...

Forbes contributors publish independent expert analyses and insights. William A. Haseltine, Ph.D., covers genomics and regenerative medicine New antiviral drugs in development could offer the ...

Cryo-EM images show drugs bound to herpes simplex virus protein at nearly atomic detail, while optical tweezer experiments show how the drug-bound protein behaves in real time. Harvard Medical School ...

Understanding a drug’s mechanism of action (MOA) can greatly increase the likelihood of successful clinical trials by identifying biomarkers of patient response and providing a rationale for ...

Varicella-zoster virus (VZV) is a clinically important human neurotropic herpesvirus that causes varicella (chickenpox) as primary infection, typically in children. After primary infection, VZV ...

Broad-spectrum antiviral agent with potential utility against Hantavirus, Ebola and LassaUtilizing a novel dual-strike mechanism, the proprietary ...

Completed enrollment in first cohort of Phase 1b challenge study evaluating CDI-988 as a preventive and as a treatment for ...

Some social media users have been saying that Merck’s experimental COVID-19 antiviral product molnupiravir is a rebranded version of the anti-parasitic Ivermectin. Two disease experts have told ...